Case number 1:21-cv-01795
Celgene Corporation et al v. MSN Laboratories Private Limited, et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 29, 2024 | 85 | CONSENT JUDGMENT AND ORDER OF DISMISSAL. Signed by Judge Jennifer L. Hall on 2/29/2024. (ceg) Modified on 2/29/2024 (ceg). (Entered: 02/29/2024) (4) |
| Feb 29, 2024 | 86 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,846,628 B2. (Attachments: # 1 Consent Judgment)(ceg) (Entered: 02/29/2024) (0) |
| Feb 28, 2024 | 84 | PROPOSED Consent Judgment and Order of Dismissal, by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Farnan, Michael) Modified on 2/28/2024 (ceg). (Entered: 02/28/2024) (4) |
| Jan 31, 2024 | 83 | STIPULATION TO EXTEND TIME Fact Discovery to February 29, 2024 - filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Farnan, Michael) (Entered: 01/31/2024) (2) |
| Dec 14, 2023 | 82 | NOTICE OF SERVICE of Defendants MSN Laboratories Private Limited and MSN Pharmaceutical, Inc.s Initial Invalidity Contentions filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) (Entered: 12/14/2023) (2) |
| Nov 27, 2023 | 81 | SO ORDERED Granting 79 Consent Judgment and Order of Dismissal (*Party Accord Healthcare Inc. terminated). Signed by Judge Richard G. Andrews on 11/27/2023. (nms) (Entered: 11/27/2023) (4) |
| Nov 21, 2023 | 79 | PROPOSED Consent Judgment and Order of Dismissal regarding Defendant Accord Healthcare Inc., by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Farnan, Brian) Modified on 11/21/2023 (nms). (Entered: 11/21/2023) (4) |
| Nov 21, 2023 | 80 | NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) (Entered: 11/21/2023) (2) |
| Nov 17, 2023 | 78 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 11/17/2023) (2) |
| Nov 14, 2023 | 77 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 11/14/2023) (2) |
| Nov 8, 2023 | 76 | REDACTED VERSION of 74 Notice to Take Deposition, by Bristol-Myers Squibb Company, Celgene Corporation. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 11/08/2023) (0) |
| Nov 6, 2023 | 75 | NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs Amended Requests for Admission (Nos. 1, 7-9, 11, 19, 21 and 50) filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 11/06/2023) (2) |
| Nov 1, 2023 | 74 | [SEALED] NOTICE to Take Deposition of MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. on 11/22/2023 filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Certificate of Service)(Farnan, Michael) (Entered: 11/01/2023) (0) |
| Oct 25, 2023 | 73 | NOTICE OF SERVICE of Plaintiffs' Amended Requests for Admission (Nos. 1, 7-9, 11, 19, and 21) filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 10/25/2023) (2) |
| Oct 10, 2023 | 72 | NOTICE OF SERVICE of (1) MSN Laboratories Private Ltd.s and MSN Pharmaceuticals, Inc.s Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-10) and (2) MSN Laboratories Private Ltd.s and MSN Pharmaceuticals, Inc.s Objections and Responses to Plaintiffs First Set of Requests for Production (Nos. 1-25) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) (Entered: 10/10/2023) (2) |
| Oct 2, 2023 | 71 | NOTICE OF SERVICE of (1) Accords First Supplemental Objections and Responses to Plaintiffs Second Set of Interrogatories to Defendant (Nos. 11-15) and (2) Defendants First Amended Objections and Responses to Plaintiffs First Set of Requests for Admission filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 10/02/2023) (2) |
| Sep 21, 2023 | 68 | NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 09/21/2023) (2) |
| Sep 21, 2023 | 69 | NOTICE OF SERVICE of Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.s Supplemental Rule 26(a)(1) Initial Disclosures filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Stamoulis, Stamatios) (Entered: 09/21/2023) (2) |
| Sep 21, 2023 | 70 | NOTICE OF SERVICE of Defendants Accord Healthcare Inc.s Supplemental Rule 26(a)(1) Initial Disclosures filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 09/21/2023) (2) |
| Sep 18, 2023 | 67 | Answer to MSN Defendants' Counterclaims (see D.I. 10 in 23-cv-699-RGA), by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Farnan, Michael) Modified on 9/19/2023 (nms). (Entered: 09/18/2023) (6) |
| Sep 7, 2023 | 66 | NOTICE OF SERVICE of (i) Plaintiffs' First Set of Interrogatories (Nos. 1-10) to Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. and (ii) Plaintiffs' First Set of Requests for Production (Nos. 1-25) to Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 09/07/2023) (2) |
| Aug 31, 2023 | 64 | Letter to The Honorable Richard G. Andrews, from Michael J. Farnan, regarding 30 month stay. (Farnan, Michael) Modified on 8/31/2023 (nms). (Entered: 08/31/2023) (1) |
| Aug 31, 2023 | 65 | SO ORDERED Granting (D.I. 9 in 23-cv-699-RGA; D.I. 61 in 21-cv-1795-RGA) Stipulation and Proposed Order to Consolidate and Modify Scheduling Order (*Reset Deadlines/Hearings: Fact Discovery completed by 1/31/2024; a 3-day Bench Trial will start on 9/23/2024, at 8:30 AM in Courtroom 6A; a Pretrial Conference is set for 9/13/2024, at 9:00 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 8/31/2023. Associated Cases: 1:21-cv-01795-RGA, 1:23-cv-00699-RGA(nms) (Entered: 08/31/2023) (6) |
| Aug 30, 2023 | 63 | ORAL ORDER: The parties are to submit a joint letter advising whether there is/are 30 month stays and whether moving the trial date will impact the possibility of the need for emergency relief. Ordered by Judge Richard G. Andrews on 8/30/2023. Associated Cases: 1:21-cv-01795-RGA, 1:23-cv-00699-RGA(nms) (Entered: 08/30/2023) (0) |
| Aug 28, 2023 | 62 | NOTICE OF SERVICE of Accords Objections and Responses to Plaintiffs Second Set of Interrogatories to Defendant (Nos. 11-15) filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 08/28/2023) (2) |
| Aug 24, 2023 | 61 | STIPULATION and [Proposed] Order to Consolidate and Modify Scheduling Order by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Exhibit A)(Farnan, Brian) (Entered: 08/24/2023) (0) |
| Aug 23, 2023 | 58 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant's Notice of Rule 30(b)(6) Deposition of Plaintiffs Celgene Corporation, Celgene International Sarl, and Bristol-Myers Squibb Company filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 08/23/2023) (2) |
| Aug 23, 2023 | 59 | MOTION for Pro Hac Vice Appearance of Attorney Nora Q.E. Passamaneck, David Mlaver, Gerard A. Salvatore, and Li-tsung Alyssa Chen - filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Farnan, Brian) (Entered: 08/23/2023) (5) |
| Aug 23, 2023 | 60 | NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs First Set of Requests for Admission filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 08/23/2023) (2) |
| Aug 14, 2023 | 57 | NOTICE OF SERVICE of (1) Defendants Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) and (2) Defendants Supplemental Invalidity Contentions filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 08/14/2023) (2) |
| Aug 2, 2023 | 56 | REDACTED VERSION of 53 Notice to Take Deposition by Accord Healthcare Inc.. (Stamoulis, Stamatios) (Entered: 08/02/2023) (15) |
| Jul 28, 2023 | 54 | REDACTED VERSION of 48 Notice to Take Deposition by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 07/28/2023) (0) |
| Jul 28, 2023 | 55 | NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories to Defendant filed by Bristol-Myers Squibb Company.(Farnan, Brian) (Entered: 07/28/2023) (2) |
| Jul 27, 2023 | 50 | NOTICE to Take Deposition of Mei Lai filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 07/27/2023) (2) |
| Jul 27, 2023 | 51 | NOTICE to Take Deposition of Jeffrey Etter filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 07/27/2023) (2) |
| Jul 27, 2023 | 52 | NOTICE to Take Deposition of Jay Backstorm filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 07/27/2023) (2) |
| Jul 27, 2023 | 53 | [SEALED] NOTICE to Take Deposition of Rule 30(b)(6) Corporate Representative filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 07/27/2023) (0) |
| Jul 24, 2023 | 48 | [SEALED] NOTICE to Take Deposition of Accord Healthcare Inc. on 8/14/2023 filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Certificate of Service)(Farnan, Michael) (Entered: 07/24/2023) (0) |
| Jul 24, 2023 | 49 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 07/24/2023) (2) |
| Jul 10, 2023 | 47 | NOTICE OF SERVICE of Celgene Corporation, Celgene International Sarl, and Bristol-Myers Squibb Company's Initial Infringement Contentions for U.S. Patent No. 11,571,436 filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 07/10/2023) (2) |
| Jun 14, 2023 | 46 | ANSWER to 45 Answer to Complaint, Counterclaim by Bristol-Myers Squibb Company.(Farnan, Brian) (Entered: 06/14/2023) (4) |
| May 24, 2023 | 45 | ANSWER to Complaint (filed in 23cv424-RGA) and COUNTERCLAIMS against all Plaintiffs, by Accord Healthcare Inc..(Stamoulis, Stamatios) Modified on 5/24/2023 (nms). (Entered: 05/24/2023) (19) |
| May 1, 2023 | 43 | STIPULATION and [Proposed] Order to Consolidate and Modify Scheduling Order by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl, Celgene International Sarl. (Attachments: # 1 Exhibit A)(Farnan, Brian) (Entered: 05/01/2023) (Main Document) (3) |
| May 1, 2023 | 44 | SO ORDERED Granting (D.I. 7 in 23-cv-424-RGA; D.I. 43 in 21-cv-1795-RGA) Stipulation and Proposed Order to Consolidate and Modify Scheduling Order (*Reset Deadlines/Hearings: Fact Discovery completed by 8/30/2023; 3 day Bench Trial is now set to start 5/20/2024, at 8:30 AM in Courtroom 6A; A Pretrial Conference is set for 5/10/2024, at 9:00 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 5/1/2023. Associated Cases: 1:21-cv-01795-RGA, 1:23-cv-00424-RGA(nms) (Entered: 05/01/2023) (5) |
| May 1, 2023 | 43 | STIPULATION and [Proposed] Order to Consolidate and Modify Scheduling Order by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl, Celgene International Sarl. (Attachments: # 1 Exhibit A)(Farnan, Brian) (Entered: 05/01/2023) (Exhibit A) (2) |
| Apr 14, 2023 | 42 | NOTICE OF SERVICE of (i) Plaintiffs' Objections and Responses to Defendant's First Set of Interrogatories (Nos. 1-7) and (ii) Plaintiffs' Objections and Responses to Defendant's First Set of Requests for Production (Nos. 1-67) filed by Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 04/14/2023) (2) |
| Mar 15, 2023 | 41 | NOTICE OF SERVICE of (1) Defendants First Set of Requests for Production (Nos. 1-67) and (2) Defendants First Set of Interrogatories (Nos. 1-7) filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 03/15/2023) (2) |
| Feb 13, 2023 | 40 | MARKMAN ORDER: I construe the disputed term "non-enteric coated tablet" as proposed by Celgene: "tablet that does not comprise a coating intended to release the active ingredient(s) beyond the stomach." (Id. at 2). The specification defines the term by express lexicography. '628 Patent at11 :42-45. I reject Defendant's proposed construction. Defendant relies on lexicography of a different term that is not part of the disputed term, and that is not part of the lexicographic definition of the disputed term either. Defendant cites the prosecution history but does not argue that it constitutes clear and unmistakable disclaimer. Defendant's construction purports to resolve a dispute between the parties, but it resolves the dispute erroneously. The argument scheduled for February 16th is CANCELLED. Signed by Judge Richard G. Andrews on 2/13/2023. (nms) (Entered: 02/13/2023) (1) |
| Feb 6, 2023 | 39 | ORAL ORDER: Due to a scheduling conflict the Markman Hearing scheduled for 2/16/2023, will now start at 2:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 2/6/2023. (nms) (Entered: 02/06/2023) (0) |
| Jan 13, 2023 | 38 | JOINT Claim Construction Brief, filed by Celgene Corporation, Celgene International Sarl. (Farnan, Brian) Modified on 1/13/2023 (nms). (Entered: 01/13/2023) (27) |
| Jan 6, 2023 | 37 | NOTICE OF SERVICE of Defendant Accord Healthcare, Inc.'s Sur-Reply Claim Construction Brief filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 01/06/2023) (2) |
| Dec 5, 2022 | 36 | Letter to The Honorable Richard G. Andrews from Michael J. Farnan regarding Markman Hearing. (Farnan, Michael) (Entered: 12/05/2022) (1) |
| Nov 7, 2022 | 35 | Joint Claim Construction Chart, by Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Farnan, Brian) Modified on 11/7/2022 (nms). (Entered: 11/07/2022) (Main Document) (2) |
| Nov 7, 2022 | 35 | Joint Claim Construction Chart, by Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Farnan, Brian) Modified on 11/7/2022 (nms). (Entered: 11/07/2022) (Exhibit A) (1) |
| Nov 7, 2022 | 35 | Joint Claim Construction Chart, by Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Farnan, Brian) Modified on 11/7/2022 (nms). (Entered: 11/07/2022) (Exhibit B) (2) |
| Nov 7, 2022 | 35 | Joint Claim Construction Chart, by Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Farnan, Brian) Modified on 11/7/2022 (nms). (Entered: 11/07/2022) (Exhibit C) (30) |
| Nov 7, 2022 | 35 | Joint Claim Construction Chart, by Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Farnan, Brian) Modified on 11/7/2022 (nms). (Entered: 11/07/2022) (Exhibit D) (30) |
| Nov 1, 2022 | 33 | NOTICE OF SERVICE of Plaintiffs' Identification of Proposed Claim Constructions filed by Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 11/01/2022) (2) |
| Nov 1, 2022 | 34 | NOTICE OF SERVICE of Defendants Identification of Proposed Claim Constructions filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 11/01/2022) (2) |
| Oct 10, 2022 | 31 | NOTICE OF SERVICE of Plaintiffs' Identification of Claim Term for Construction filed by Celgene Corporation, Celgene International Sarl.(Farnan, Michael) (Entered: 10/10/2022) (2) |
| Oct 10, 2022 | 32 | NOTICE OF SERVICE of Defendants Identification of Claim Term for Construction filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 10/10/2022) (2) |
| Sep 8, 2022 | 28 | ORAL ORDER: Plaintiffs are directed to file a response to the Motion for Extension of Time to Serve Initial Invalidity Contentions (D.I. 27 ) by no later than midnight tonight. Ordered by Judge Richard G. Andrews on 9/8/2022. (nms) (Entered: 09/08/2022) (0) |
| Sep 8, 2022 | 29 | RESPONSE to 27 MOTION for Extension of Time to Serve Initial Invalidity Contentions, filed by Celgene Corporation. (Farnan, Brian) Modified on 9/8/2022 (nms). (Entered: 09/08/2022) (2) |
| Sep 8, 2022 | 30 | SO ORDERED, Granting 27 MOTION for Extension of Time to Serve Initial Invalidity Contentions. Signed by Judge Richard G. Andrews on 9/8/2022. (nms) (Entered: 09/08/2022) (4) |
| Sep 7, 2022 | 27 | MOTION for Extension of Time to Serve Initial Invalidity Contentions - filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) Modified on 9/7/2022 (nms). (Entered: 09/07/2022) (4) |
| Aug 1, 2022 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Celgene Corporation and Celgene International Sarl's Initial Infringement Contentions filed by Celgene Corporation, Celgene International Sarl.(Farnan, Michael) |
| Jul 25, 2022 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Accords Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-10) and (2) Accords Objections and Responses to Plaintiffs First Set of Requests for Production (Nos. 1-25) filed by Accord Healthcare Inc..(Stamoulis, Stamatios) |
| Jun 23, 2022 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Plaintiffs' First Set of Interrogatories to Defendant and (ii) Plaintiffs' First Set of Requests for Production (Nos. 1-25) filed by Celgene Corporation, Celgene International Sarl.(Farnan, Michael) |
| Jun 1, 2022 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Celgene Corporation and Celgene International Sarl's Disclosures Pursuant to Paragraphs 3 and 4a of The Delaware Default Standard for Discovery filed by Celgene Corporation, Celgene International Sarl.(Farnan, Michael) |
| Jun 1, 2022 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Accord Healthcare, Inc.s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Accord Healthcare Inc..(Stamoulis, Stamatios) |
| May 18, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Neal Seth, Wesley E. Weeks, and Corey Weinstein for Accord Healthcare Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 16, 2022 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Celgene Corporation, Celgene International Sarl.(Farnan, Michael) |
| May 16, 2022 | 21 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Accord Healthcare, Inc.s Rule 26(a)(1) Initial Disclosures filed by Accord Healthcare Inc..(Stamoulis, Stamatios) |
| May 9, 2022 | 18 | Proposed Order (21) Docket Text: PROPOSED Protective Order, by Celgene Corporation, Celgene International Sarl. (Farnan, Michael) Modified on 5/9/2022 (nms). |
| May 9, 2022 | 19 | Order (21) Docket Text: SO ORDERED Granting [18] Proposed Protective Order. Signed by Judge Richard G. Andrews on 5/9/2022. (nms) |
| May 5, 2022 | 17 | Answer to Counterclaim (4) Docket Text: ANSWER to [8] Answer to Complaint and Counterclaims, by Celgene Corporation, Celgene International Sarl.(Farnan, Michael) Modified on 5/6/2022 (nms). |
| May 4, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrew J. Danford for Celgene Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 4, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Heather M. Petruzzi for Celgene Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Heather M. Petruzzi, and Andrew J. Danford, filed by Celgene Corporation, Celgene International Sarl. Signed by Judge Richard G. Andrews on 5/3/2022. (nms) |
| May 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Neal Seth, Wesley Weeks, and Corey Weinstein, filed by Accord Healthcare Inc.. Signed by Judge Richard G. Andrews on 5/3/2022. (nms) |
| May 2, 2022 | 15 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Heather M. Petruzzi, and Andrew J. Danford - filed by Celgene Corporation, Celgene International Sarl. (Farnan, Brian) |
| May 2, 2022 | 16 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Neal Seth, Wesley Weeks, and Corey Weinstein - filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| Apr 29, 2022 | 13 | Scheduling Order (10) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 11/2/2022. Amended Pleadings due by 11/2/2022. Fact Discovery completed by 6/29/2023. Joint Claim Construction Brief due by 1/13/2023. A Markman Hearing is set for 2/16/2023, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 3/8/2024, at 8:30 AM in Courtroom 6A. A 3 day Bench Trial is set to start 3/18/2024, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 4/29/2022. (nms) |
| Apr 29, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference scheduled for 5/2/2022, is CANCELED. Ordered by Judge Richard G. Andrews on 4/29/2022. (nms) |
| Apr 28, 2022 | 12 | Main Document (12) Docket Text: PROPOSED Scheduling Order, by Celgene Corporation, Celgene International Sarl. (Attachments: # (1) Letter)(Farnan, Michael) Modified on 4/28/2022 (nms). |
| Apr 28, 2022 | 12 | Letter to The Honorable Richard G. Andrews (1) |
| Apr 27, 2022 | 11 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Michael J. Farnan regarding Dial In for May 2, 2022 Scheduling Conference. (Farnan, Michael) |
| Apr 19, 2022 | 10 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 5/2/2022, at 4:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 4/19/2022. (nms) |
| Apr 14, 2022 | 8 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against Celgene Corporation, Celgene International Sarl, by Accord Healthcare Inc..(Stamoulis, Stamatios) Modified on 4/14/2022 (nms). |
| Apr 14, 2022 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Intas Pharmaceuticals Ltd. for Accord Healthcare Inc. filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| Mar 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Accord Healthcare Inc. answer due 4/14/2022). Signed by Judge Richard G. Andrews on 3/11/2022. (nms) |
| Mar 10, 2022 | 7 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to April 14, 2022 - filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| Jan 14, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [6] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to 3/14/2022 (*Reset Answer Deadlines: Accord Healthcare Inc. answer due 3/14/2022). Signed by Judge Richard G. Andrews on 1/14/2022. (nms) |
| Jan 13, 2022 | 6 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Defendant to answer, move, or otherwise respond to the Complaint to 3/14/2022 - filed by Celgene Corporation, Celgene International Sarl. (Farnan, Michael) |
| Dec 29, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Dec 22, 2021 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (myr) |
| Dec 22, 2021 | 1 | Main Document (10) Docket Text: COMPLAINT filed against Accord Healthcare Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3769141.) - filed by Celgene Corporation, Celgene International Sarl. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(myr) |
| Dec 22, 2021 | 1 | Exhibit A (71) |
| Dec 22, 2021 | 1 | Exhibit B (24) |
| Dec 22, 2021 | 1 | Civil Cover Sheet (1) |
| Dec 22, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Dec 22, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 16, 2021. Date of Expiration of Patent: June 3, 2030.Thirty Month Stay Deadline: 5/16/2024. (myr) |
| Dec 22, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,846,628 B2. (myr) |
| Dec 22, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Celgene Corporation for Celgene International Sarl; Corporate Parent Bristol-Myers Squibb Company for Celgene Corporation filed by Celgene Corporation, Celgene International Sarl. (myr) |
| Dec 22, 2021 | 1 | Complaint* (1) |
